 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW SUBCLINICAL ENDOCRINE DISEASE: OLD AND NEW CLINICAL SCENARIOS
Minerva Endocrinology 2021 September;46(3):238-42
DOI: 10.23736/S2724-6507.20.03176-4
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Subclinical hypothyroidism
Jessica CHBAT 1, Shereen EZZAT 1, Giampaolo PAPI 2 ✉
1 Endocrine Oncology Site Group, Princess Margaret Cancer Center, Toronto, Canada; 2 Unit of Endocrinology, Northern Area, USL Modena, Modena, Italy
Subclinical hypothyroidism (i.e. a condition characterized by serum TSH concentrations above the normal reference range in the presence of normal serum T4 levels) affects 4 to 20% of the population living in iodine-sufficient areas. The present work reviewed the clinical challenges regarding the signs and symptoms possibly related to subclinical hypothyroidism and the most recent guideline recommendations to treatment.
KEY WORDS: Hypothyroidism; Thyroid diseases; Diagnosis; Therapeutics